… . FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin …

On Friday, the benchmark Sensex dropped by 501 points, closing at 81,757. However, even amid the broader market weakness, 10 stocks from the BSE 500 Index defied the trend by hitting their 52-week highs — reaching their highest levels in a year. Such …

… . Notable names among them include Biocon, HDFC Asset Management, and Nippon …

… , FMCG, realty, and IT sectors. Biocon, RBL Bank, and HDFC AMC … -week highs. Analysts suggest monitoring Biocon for a breakout above 425 …

… ;s biosimilars arm Biocon Biologics announced that the US … , CEO & MD, Biocon Biologics said. Besides Biocon, in February this year …

… [REUTER/YONHAP]   Biocon aims to launch generic copies … and Zepbound.   Biopharmaceutical company Biocon plans to submit a request … , he added.   "Biocon is actively progressing with filings …   In addition to Canada, Biocon will focus on large emerging …

… Sadam HYDERABAD (Reuters) -Biocon aims to launch generic copies … and Zepbound. Biopharmaceutical company Biocon plans to submit a … months, he added. “Biocon is actively progressing with filings … In addition to Canada, Biocon will focus on large emerging …

… company and subsidiary of Biocon Ltd., has received approval … approval of KIRSTY expands Biocon Biologics’ biosimilar insulin portfolio … CEO & Managing Director, Biocon Biologics Ltd., said, “The … 5.8M patients annually, Biocon Biologics has a comprehensive …

… company and subsidiary of Biocon announced that US FDA … FDA approval of Kirsty expands Biocon Biologics’ biosimilar insulin portfolio, … CEO & managing director, Biocon Biologics, said: “The FDA … .   The Bengaluru-based Biocon Biologics is a global leader …

… on both pharma counters. Biocon and Zydus Lifesciences are … and renewed retail interest.  Biocon shares rose 2% on Wednesday … on these two pharma counters:  Biocon Biocon Biologics, its arm, secured … ‘bearish’ last week. Biocon sentiment and message volume on …